CAH vs TWST · P/E 35, rev $254.25B vs rev $332.8M
Cardinal Health Inc (CAH) versus Twist Bioscience Corp (TWST) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Twist Bioscience Corp (TWST) is a diagnostics & research company listed on NASDAQ.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported TWST revenue for 2026-06-30 was $332.8M. Net income was -$109.6M. Revenue was up 55.2% from 2026-03-31 to 2026-06-30. TWST currently screens at market cap $5.16B.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. TWST currently screens at market cap $5.16B.
Not investment advice. Open the CAH and TWST stock pages for the full models.
Not investment advice.